177 related articles for article (PubMed ID: 37936126)
21. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
[TBL] [Abstract][Full Text] [Related]
22. Unbiased Analysis of Temporal Changes in Immune Serum Markers in Acute COVID-19 Infection With Emphasis on Organ Failure, Anti-Viral Treatment, and Demographic Characteristics.
Laudanski K; Jihane H; Antalosky B; Ghani D; Phan U; Hernandez R; Okeke T; Wu J; Rader D; Susztak K
Front Immunol; 2021; 12():650465. PubMed ID: 34177897
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatment of pancreatic head and periampullary tumors.
Kovács I; Tóth P; Arkosy P; Hámori J; Sápy P
Acta Chir Hung; 1997; 36(1-4):172-3. PubMed ID: 9408334
[TBL] [Abstract][Full Text] [Related]
24. High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas.
Jeong BK; Sung YN; Kim SJ; An S; Park H; Hwang HS; Kang HJ; Lee JH; Song KB; Kim KP; Hwang DW; Lee SS; Kim SC; Hong SM
Hum Pathol; 2019 Feb; 84():92-104. PubMed ID: 30261192
[TBL] [Abstract][Full Text] [Related]
25. Apparent diffusion coefficient-based histogram analysis differentiates histological subtypes of periampullary adenocarcinoma.
Lu JY; Yu H; Zou XL; Li Z; Hu XM; Shen YQ; Hu DY
World J Gastroenterol; 2019 Oct; 25(40):6116-6128. PubMed ID: 31686767
[TBL] [Abstract][Full Text] [Related]
26. Survival analysis of pancreatic and periampullary collision cancers.
Niu GM; Jin DY; Ji Y; Hou J; Wang DS; Lou WH
J Dig Dis; 2010 Aug; 11(4):231-6. PubMed ID: 20649736
[TBL] [Abstract][Full Text] [Related]
27. Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.
Boyd LNC; Ali M; Comandatore A; Garajova I; Kam L; Puik JR; Fraga Rodrigues SM; Meijer LL; Le Large TYS; Besselink MG; Morelli L; Frampton A; van Laarhoven HWM; Giovannetti E; Kazemier G
JAMA Netw Open; 2023 Aug; 6(8):e2331197. PubMed ID: 37639271
[TBL] [Abstract][Full Text] [Related]
28. Primary squamous cell carcinoma of the ampulla of Vater: management and review of the literature.
Soni S; Elhence P; Varshney VK; Suman S
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33414110
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.
Allen VB; Gurusamy KS; Takwoingi Y; Kalia A; Davidson BR
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009323. PubMed ID: 27383694
[TBL] [Abstract][Full Text] [Related]
31. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies.
Friess H; Kleeff J; Silva JC; Sadowski C; Baer HU; Büchler MW
J Am Coll Surg; 1998 Jun; 186(6):675-82. PubMed ID: 9632157
[TBL] [Abstract][Full Text] [Related]
32. [Periampullary carcinoma or tumor of the ampulla of Vater?].
Vasilescu C; Herlea V; Stoicescu M
Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
[TBL] [Abstract][Full Text] [Related]
33. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin.
Komine R; Kojima M; Ishi G; Kudo M; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Kobayashi T; Akimoto T; Murakami A; Sasaki M; Tanaka M; Matsuzaki A; Ohike N; Uchida K; Sugiyama T; Hirabayashi K; Tajiri T; Ishida K; Kai K; Omori Y; Notohara K; Yamaguchi H; Matsuda Y; Naito Y; Fukumura Y; Hamada Y; Mihara Y; Masugi Y; Gotohda N; Harada K; Fukushima N; Furukawa T
Cancer Med; 2021 Jun; 10(11):3499-3510. PubMed ID: 34008914
[TBL] [Abstract][Full Text] [Related]
34. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial.
Lillemoe KD; Cameron JL; Hardacre JM; Sohn TA; Sauter PK; Coleman J; Pitt HA; Yeo CJ
Ann Surg; 1999 Sep; 230(3):322-8; discussion 328-30. PubMed ID: 10493479
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group.
Klinkenbijl JH; Jeekel J; Sahmoud T; van Pel R; Couvreur ML; Veenhof CH; Arnaud JP; Gonzalez DG; de Wit LT; Hennipman A; Wils J
Ann Surg; 1999 Dec; 230(6):776-82; discussion 782-4. PubMed ID: 10615932
[TBL] [Abstract][Full Text] [Related]
36. Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma.
Lundgren S; Micke P; Elebro J; Heby M; Hrynchyk I; Nodin B; Leandersson K; Mezheyeuski A; Jirström K
Front Immunol; 2020; 11():558169. PubMed ID: 33013928
[TBL] [Abstract][Full Text] [Related]
37. Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors.
Petzel MQ; Parker NH; Valentine AD; Simard S; Nogueras-Gonzalez GM; Lee JE; Pisters PW; Vauthey JN; Fleming JB; Katz MH
Ann Surg Oncol; 2012 Dec; 19(13):4078-84. PubMed ID: 22875648
[TBL] [Abstract][Full Text] [Related]
38. Durable response for ampullary and duodenal adenocarcinoma with a nab-paclitaxel plus gemcitabine ± cisplatin combination.
Cen P; Wray CJ; Zhang S; Thosani NC; Dinh BC; Gonzalez A; Mohlere V; Bynon JS
Cancer Med; 2019 Jul; 8(7):3464-3470. PubMed ID: 31102323
[TBL] [Abstract][Full Text] [Related]
39. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome?
Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C
Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717
[TBL] [Abstract][Full Text] [Related]
40. Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue.
Booy S; Hofland LJ; Waaijers AM; Croze E; van Koetsveld PM; de Vogel L; Biermann K; van Eijck CH
Pancreas; 2015 Jan; 44(1):99-105. PubMed ID: 25072284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
